Tech Company Financing Transactions
LQ3 Pharmaceuticals Funding Round
LQ3 Pharmaceuticals closed a $2.4 million investment round on 9/30/2015. Investors included Canaan Partners.
Transaction Overview
Company Name
Announced On
9/30/2015
Transaction Type
Venture Equity
Amount
$2,439,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
419 Davis Dr. 100
Morrisville, NC 27560
USA
Morrisville, NC 27560
USA
Phone
Website
Email Address
Not Recorded
Overview
Lq3 Pharmaceuticals, formed by Liquidia Technologies in 2014, is a privately held company focused on the development of innovative oral health therapies. Lq3 is leveraging the unique and powerful properties of the PRINT® technology to research and develop novel therapies for a variety of oral health conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kyle Chenet
Vice President
Diane Ignar
VP - Engineering
Kevin Herlihy
Browse more venture capital transactions:
Prev: 9/30/2015: WriteLab venture capital transaction
Next: 9/30/2015: ShotSpotter venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs